NeoGenomics, Inc. (NEO)
USD 9.72
(4.29%)
USD 9.72
(4.29%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 244.6 Million USD | 30.18% |
| 2022 | 187.89 Million USD | 0.45% |
| 2021 | 187.06 Million USD | 0.63% |
| 2020 | 185.89 Million USD | -5.56% |
| 2019 | 196.83 Million USD | 54.67% |
| 2018 | 127.26 Million USD | 5.78% |
| 2017 | 120.31 Million USD | 9.0% |
| 2016 | 110.37 Million USD | 152.26% |
| 2015 | 43.75 Million USD | 7.47% |
| 2014 | 40.71 Million USD | 28.29% |
| 2013 | 31.73 Million USD | 18.26% |
| 2012 | 26.83 Million USD | 38.13% |
| 2011 | 19.42 Million USD | 23.09% |
| 2010 | 15.78 Million USD | 3.73% |
| 2009 | 15.21 Million USD | 42.71% |
| 2008 | 10.66 Million USD | 78.23% |
| 2007 | 5.98 Million USD | 60.94% |
| 2006 | 3.71 Million USD | 433.32% |
| 2005 | 696.92 Thousand USD | 3808.41% |
| 2004 | -18.79 Thousand USD | 83.16% |
| 2003 | -111.62 Thousand USD | -15.71% |
| 2002 | -96.46 Thousand USD | -9746.7% |
| 2001 | 1000.00 USD | -99.44% |
| 2000 | 178.11 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 69.04 Million USD | 11.33% |
| 2024 Q3 | 74.88 Million USD | 8.46% |
| 2024 Q1 | 62.01 Million USD | -8.24% |
| 2023 Q3 | 62.31 Million USD | 4.04% |
| 2023 Q4 | 67.58 Million USD | 8.47% |
| 2023 FY | 244.6 Million USD | 30.18% |
| 2023 Q1 | 54.81 Million USD | -3.54% |
| 2023 Q2 | 59.89 Million USD | 9.26% |
| 2022 Q3 | 48.89 Million USD | 11.26% |
| 2022 Q1 | 38.23 Million USD | -15.52% |
| 2022 Q4 | 56.82 Million USD | 16.22% |
| 2022 FY | 187.89 Million USD | 0.45% |
| 2022 Q2 | 43.94 Million USD | 14.95% |
| 2021 Q1 | 41.57 Million USD | -27.64% |
| 2021 Q2 | 52.99 Million USD | 27.46% |
| 2021 Q4 | 45.25 Million USD | -4.2% |
| 2021 FY | 187.06 Million USD | 0.63% |
| 2021 Q3 | 47.23 Million USD | -10.85% |
| 2020 Q4 | 57.45 Million USD | 6.27% |
| 2020 Q2 | 28 Million USD | -39.6% |
| 2020 Q1 | 46.36 Million USD | -7.12% |
| 2020 FY | 185.89 Million USD | -5.56% |
| 2020 Q3 | 54.06 Million USD | 93.05% |
| 2019 Q4 | 49.92 Million USD | -1.79% |
| 2019 Q3 | 50.83 Million USD | 3.81% |
| 2019 Q2 | 48.96 Million USD | 3.93% |
| 2019 Q1 | 47.11 Million USD | 26.96% |
| 2019 FY | 196.83 Million USD | 54.67% |
| 2018 Q1 | 27.3 Million USD | -17.59% |
| 2018 Q2 | 30.53 Million USD | 11.82% |
| 2018 Q3 | 32.32 Million USD | 5.87% |
| 2018 Q4 | 37.11 Million USD | 14.82% |
| 2018 FY | 127.26 Million USD | 5.78% |
| 2017 Q3 | 28.81 Million USD | -7.6% |
| 2017 FY | 120.31 Million USD | 9.0% |
| 2017 Q4 | 33.13 Million USD | 15.0% |
| 2017 Q2 | 31.17 Million USD | 14.64% |
| 2017 Q1 | 27.19 Million USD | -0.23% |
| 2016 Q3 | 27.34 Million USD | -4.4% |
| 2016 FY | 110.37 Million USD | 152.26% |
| 2016 Q1 | 27.17 Million USD | 122.22% |
| 2016 Q2 | 28.6 Million USD | 5.27% |
| 2016 Q4 | 27.25 Million USD | -0.32% |
| 2015 Q1 | 9.54 Million USD | -16.81% |
| 2015 Q4 | 12.22 Million USD | 9.46% |
| 2015 Q3 | 11.17 Million USD | 3.31% |
| 2015 FY | 43.75 Million USD | 7.47% |
| 2015 Q2 | 10.81 Million USD | 13.3% |
| 2014 Q4 | 11.47 Million USD | 11.44% |
| 2014 FY | 40.71 Million USD | 28.29% |
| 2014 Q1 | 8.7 Million USD | -4.95% |
| 2014 Q2 | 10.23 Million USD | 17.57% |
| 2014 Q3 | 10.29 Million USD | 0.54% |
| 2013 Q3 | 8.17 Million USD | 14.17% |
| 2013 Q2 | 7.15 Million USD | -1.23% |
| 2013 Q1 | 7.24 Million USD | 12.62% |
| 2013 FY | 31.73 Million USD | 18.26% |
| 2013 Q4 | 9.16 Million USD | 12.14% |
| 2012 Q1 | 7.14 Million USD | 22.48% |
| 2012 FY | 26.83 Million USD | 38.13% |
| 2012 Q4 | 6.43 Million USD | 9.2% |
| 2012 Q2 | 7.36 Million USD | 3.12% |
| 2012 Q3 | 5.89 Million USD | -20.02% |
| 2011 Q2 | 4.65 Million USD | 20.47% |
| 2011 FY | 19.42 Million USD | 23.09% |
| 2011 Q3 | 5.07 Million USD | 8.98% |
| 2011 Q4 | 5.83 Million USD | 14.96% |
| 2011 Q1 | 3.86 Million USD | -1.0% |
| 2010 Q4 | 3.9 Million USD | 0.36% |
| 2010 FY | 15.78 Million USD | 3.73% |
| 2010 Q3 | 3.89 Million USD | -0.64% |
| 2010 Q1 | 4.07 Million USD | 10.35% |
| 2010 Q2 | 3.91 Million USD | -3.9% |
| 2009 FY | 15.21 Million USD | 42.71% |
| 2009 Q3 | 3.62 Million USD | -11.06% |
| 2009 Q4 | 3.69 Million USD | 1.86% |
| 2009 Q1 | 3.82 Million USD | 21.6% |
| 2009 Q2 | 4.07 Million USD | 6.6% |
| 2008 Q2 | 2.69 Million USD | 17.07% |
| 2008 FY | 10.66 Million USD | 78.23% |
| 2008 Q4 | 3.14 Million USD | 24.99% |
| 2008 Q3 | 2.51 Million USD | -6.75% |
| 2008 Q1 | 2.3 Million USD | 21.51% |
| 2007 Q1 | 1.3 Million USD | 27.15% |
| 2007 Q3 | 1.6 Million USD | 35.92% |
| 2007 Q4 | 1.89 Million USD | 18.42% |
| 2007 FY | 5.98 Million USD | 60.94% |
| 2007 Q2 | 1.17 Million USD | -9.78% |
| 2006 Q4 | 1.02 Million USD | 16.58% |
| 2006 FY | 3.71 Million USD | 433.32% |
| 2006 Q3 | 881.01 Thousand USD | -15.42% |
| 2006 Q2 | 1.04 Million USD | 35.81% |
| 2006 Q1 | 767 Thousand USD | 211.55% |
| 2005 FY | 696.92 Thousand USD | 3808.41% |
| 2005 Q1 | 53.35 Thousand USD | 323.11% |
| 2005 Q4 | 246.18 Thousand USD | 0.01% |
| 2005 Q3 | 246.17 Thousand USD | 62.8% |
| 2005 Q2 | 151.2 Thousand USD | 183.41% |
| 2004 Q3 | -10.91 Thousand USD | 35.2% |
| 2004 Q2 | -16.84 Thousand USD | -151.23% |
| 2004 FY | -18.79 Thousand USD | 83.16% |
| 2004 Q1 | 32.87 Thousand USD | 449.57% |
| 2004 Q4 | -23.91 Thousand USD | -119.11% |
| 2003 Q1 | -26.87 Thousand USD | -781.74% |
| 2003 Q4 | -9405.00 USD | 74.7% |
| 2003 FY | -111.62 Thousand USD | -15.71% |
| 2003 Q3 | -37.17 Thousand USD | 2.58% |
| 2003 Q2 | -38.16 Thousand USD | -42.01% |
| 2002 Q4 | 3942.00 USD | 111.89% |
| 2002 Q1 | - USD | 0.0% |
| 2002 Q3 | -33.16 Thousand USD | 46.86% |
| 2002 FY | -96.46 Thousand USD | -9746.7% |
| 2002 Q2 | -62.41 Thousand USD | 0.0% |
| 2001 Q2 | 1.00 USD | 0.0% |
| 2001 Q4 | - USD | 0.0% |
| 2001 Q1 | 1.00 USD | 0.0% |
| 2001 Q3 | - USD | -100.0% |
| 2001 FY | 1000.00 USD | -99.44% |
| 2000 Q2 | 91.06 Thousand USD | 4.61% |
| 2000 Q3 | 1.00 USD | -100.0% |
| 2000 Q4 | - USD | -100.0% |
| 2000 FY | 178.11 Thousand USD | 0.0% |
| 2000 Q1 | 87.04 Thousand USD | 0.0% |
| 1999 Q1 | - USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Aspira Women's Health Inc. | 5.26 Million USD | -4548.499% |
| bioAffinity Technologies, Inc. | 791.61 Thousand USD | -30799.364% |
| Intelligent Bio Solutions Inc. | 1.42 Million USD | -17057.656% |
| Standard BioTools Inc. | 50.45 Million USD | -384.844% |
| Inotiv, Inc. | 165.44 Million USD | -47.848% |
| Prenetics Global Limited | 8.82 Million USD | -2670.183% |
| Neuronetics, Inc. | 51.7 Million USD | -373.076% |
| Star Equity Holdings, Inc. | 11.92 Million USD | -1951.015% |
| Castle Biosciences, Inc. | 174.8 Million USD | -39.929% |
| Psychemedics Corporation | 8.41 Million USD | -2807.453% |
| RadNet, Inc. | 93 Million USD | -163.015% |
| Exact Sciences Corporation | 1.84 Billion USD | 86.746% |
| IDEXX Laboratories, Inc. | 2.18 Billion USD | 88.831% |
| iSpecimen Inc. | 5.1 Million USD | -4688.724% |
| OpGen, Inc. | -90.69 Thousand USD | 269802.516% |
| Exagen Inc. | 29.45 Million USD | -730.405% |
| Bionano Genomics, Inc. | 9.56 Million USD | -2457.014% |
| CareDx, Inc | 178.32 Million USD | -37.168% |
| Check-Cap Ltd. | -212 Thousand USD | 115479.245% |
| Twist Bioscience Corporation | 133.34 Million USD | -83.431% |
| Guardant Health, Inc. | 336.89 Million USD | 27.395% |
| Biodesix, Inc. | 36.07 Million USD | -578.005% |
| BioNexus Gene Lab Corp. | 1.32 Million USD | -18298.222% |
| Precipio, Inc. | 6.01 Million USD | -3964.54% |
| Natera, Inc. | 492.74 Million USD | 50.358% |
| Fulgent Genetics, Inc. | 104.45 Million USD | -134.169% |
| Sera Prognostics, Inc. | 96 Thousand USD | -254695.833% |
| 23andMe Holding Co. | 99.37 Million USD | -146.137% |
| OPKO Health, Inc. | 318.12 Million USD | 23.111% |
| Personalis, Inc. | 18.2 Million USD | -1243.388% |
| Aclaris Therapeutics, Inc. | 13.16 Million USD | -1757.564% |
| Applied DNA Sciences, Inc. | 5.53 Million USD | -4320.475% |
| T2 Biosystems, Inc. | -8.17 Million USD | 3093.929% |
| Neogen Corporation | 463.9 Million USD | 47.272% |
| Myriad Genetics, Inc. | 476.4 Million USD | 48.656% |
| ICON Public Limited Company | 1.81 Billion USD | 86.518% |
| Star Equity Holdings, Inc. | 11.92 Million USD | -1951.015% |
| MDxHealth SA | 43.92 Million USD | -456.817% |
| Prenetics Global Limited | 8.82 Million USD | -2670.183% |
| Illumina, Inc. | 2.74 Billion USD | 91.086% |
| DarioHealth Corp. | 5.98 Million USD | -3987.634% |
| ENDRA Life Sciences Inc. | -275.45 Thousand USD | 88901.275% |
| Medpace Holdings, Inc. | 524.5 Million USD | 53.365% |
| Mainz Biomed B.V. | 509.65 Thousand USD | -47893.659% |
| Trinity Biotech plc | 19.45 Million USD | -1157.604% |
| Sotera Health Company | 577.15 Million USD | 57.619% |
| bioAffinity Technologies, Inc. | 791.61 Thousand USD | -30799.364% |